These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Kang HJ; Shin HY; Choi HS; Ahn HS Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866 [TBL] [Abstract][Full Text] [Related]
25. Conditioning with high-dose cyclophosphamide may not be sufficient to provide a long-term remission of paroxysmal nocturnal hemoglobinuria following syngeneic peripheral blood stem cell transplantation. Cho SG; Lim J; Kim Y; Eom HS; Jin CY; Han CW; Kim CC Bone Marrow Transplant; 2001 Nov; 28(10):987-8. PubMed ID: 11753556 [TBL] [Abstract][Full Text] [Related]
26. Current status of allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria. Matos-Fernandez NA; Abou Mourad YR; Caceres W; Kharfan-Dabaja MA Biol Blood Marrow Transplant; 2009 Jun; 15(6):656-61. PubMed ID: 19450749 [TBL] [Abstract][Full Text] [Related]
27. Allogeneic bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Araten DJ; Luzzatto L Haematologica; 2000 Jan; 85(1):1-2. PubMed ID: 10627666 [No Abstract] [Full Text] [Related]
29. Catheter-directed thrombolysis and thrombectomy for the Budd-Chiari syndrome in paroxysmal nocturnal hemoglobinuria in three patients. Kuo GP; Brodsky RA; Kim HS J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):383-7. PubMed ID: 16517788 [TBL] [Abstract][Full Text] [Related]
30. Identical twin marrow transplantation for venous thrombosis in paroxysmal nocturnal hemoglobinuria; long-term complete remission as assessed by flow cytometry. Doukas MA; Fleming D; Jennings D Bone Marrow Transplant; 1998 Oct; 22(7):717-21. PubMed ID: 9818702 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566 [TBL] [Abstract][Full Text] [Related]
32. [Clinical profile and course of paroxysmal nocturnal hemoglobinuria]. Tudela M; Jarque I; Pérez-Sirvent ML; Palau J; Sanz MA Sangre (Barc); 1993 Aug; 38(4):301-7. PubMed ID: 8235945 [TBL] [Abstract][Full Text] [Related]
33. [Successful management of orthopedic operations requiring general anesthesia in a PNH patient after introduction of eculizumab]. Tsutsui M; Gotoh A; Yasuda H; Ono E; Tanaka M; Komatsu N Rinsho Ketsueki; 2015 Apr; 56(4):423-7. PubMed ID: 25971274 [TBL] [Abstract][Full Text] [Related]
34. [Expression of phosphorylated STAT5 in bone marrow hematopoietic stem cells of patients with paroxysmal nocturnal hemoglobinuria before and after in vitro G-CSF or SCF stimulation]. Ding SX; Fu R; Wang HL; Zhang T; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Wang HQ; Xing LM; Guan J; Wang J; Li LJ; Shao ZH Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(14):956-9. PubMed ID: 22781567 [TBL] [Abstract][Full Text] [Related]
35. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria. Shichishima T; Noji H Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783 [TBL] [Abstract][Full Text] [Related]
36. Bone marrow transplant for a girl with bone marrow failure and cerebral palsy. Kodama Y; Okamoto Y; Shinkoda Y; Tanabe T; Nishikawa T; Yamaki Y; Kurauchi K; Kawano Y Pediatr Int; 2014 Jun; 56(3):424-6. PubMed ID: 24894930 [TBL] [Abstract][Full Text] [Related]
37. [New therapeutic possibilities for acquired clonal blood diseases and myelodysplasia]. Brinch L; Evensen SA; Hammerstrøm J; Blichfeldt P Tidsskr Nor Laegeforen; 1992 Aug; 112(18):2343-5. PubMed ID: 1412233 [TBL] [Abstract][Full Text] [Related]
38. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders. Agarwal R; Chapple P; Brown M; Szer J; Juneja S Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736 [TBL] [Abstract][Full Text] [Related]
39. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786 [TBL] [Abstract][Full Text] [Related]
40. A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A Cytometry B Clin Cytom; 2013 Mar; 84(2):71-81. PubMed ID: 23281097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]